AI Science Tracker

De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data Regime.

University of Perugia; Ludwig-Maximilians-Universität München; University Medical Center Utrecht · 31 May 2023 · medicine

Discovery

De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data Regime.

Source check: Needs source check. Not independent scientific confirmation.

Finding / tested result: A ligand-fine-tuned neural generator prioritized structurally novel Nurr1 agonists with measured potency and binding affinity. Early chemical leads, without animal or clinical efficacy.

Technology: Fragment-augmented generative chemical language model

Publication: Publication status unspecified in annotation · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Fragment-augmented generative chemical language model is the AI method documented in the editorial source review.
Limitation / still unknown
The date refers to the cited version. Earlier public versions and independent replication were not systematically verified.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1021/acs.jmedchem.3c00485

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.